Present-day anthelmintics and perspectives on future new targets

Area of Science:

• Parasitology
• Drug Discovery
• Neuroscience

Background:

• Chemotherapy remains the primary method for controlling human helminthiases.
• Limited drug availability and increasing anthelmintic resistance necessitate new treatments.
• Current drug discovery methods are often costly and time-consuming.

Purpose of the Study:

• To highlight the urgent need for novel anthelmintic agents.
• To emphasize the importance of understanding drug mechanisms and targets.
• To propose the helminth nervous system as a promising target for new drug development.

Main Methods:

• Review of current challenges in anthelmintic drug development.
• Discussion of traditional versus novel drug discovery approaches.
• Exploration of the helminth nervous system, neurotransmitters, and receptors.

Main Results:

• The nervous system is a validated target for various chemotherapeutics.
• Advances in helminth neuroscience provide a foundation for targeted drug design.
• Identifying specific neural targets could lead to effective new anthelmintics.

Conclusions:

• The development of new anthelmintic agents is critical.
• Mechanism-based drug discovery focusing on the helminth nervous system is a viable strategy.
• Targeting helminth neurotransmission holds significant potential for combating parasitic infections.